NCT06604052

Brief Summary

The traditional positioning and surgical methods for temporary ileostomy no longer meet the requirements of minimally invasive surgery: (1) Conventional stoma positioning often leads to the trocar incision being too close to the stoma site, increasing the risk of baseplate leakage and skin infection. (2) Since stoma positioning is required to be within the rectus abdominis, the proximity between the stoma and auxiliary incision can heighten difficulties in stoma bag attachment and raises the risk of fecal leakage. (3) Stoma retraction surgery within the rectus abdominis is more traumatic and complex. We introduce for the first time a modified stoma positioning and surgical method, termed Reduced-Port Fusion Surgery. This technique includes preoperative trocar/stoma fusion positioning and intraoperative trocar/stoma fusion surgery. The procedure is based on the 3R principles: Reposition - the stoma is repositioned within the Joint Trocar/Stoma Zone, allowing for more lateral placement to meet surgical needs without being confined to the rectus abdominis. Reduce Port - the same fusion point is used for both trocar insertion and stoma creation, enabling dual use of one site. Recognize - surgeons participate in stoma positioning, recognize the positioning, and follow the procedure. This prospective, randomized, parallel-controlled clinical study aims to evaluate whether Reduced-Port Fusion Surgery can reduce stoma-related complications, postoperative pain, improve quality of life, and facilitate stoma retraction surgery compared to traditional methods. A total of 80 participants will be randomly assigned in a 1:1 ratio. The experimental group will undergo Reduced-Port Fusion Surgery while the control group will receive traditional surgery.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2024

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 6, 2024

Completed
10 days until next milestone

First Submitted

Initial submission to the registry

September 16, 2024

Completed
3 days until next milestone

First Posted

Study publicly available on registry

September 19, 2024

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

September 19, 2024

Status Verified

September 1, 2024

Enrollment Period

1.3 years

First QC Date

September 16, 2024

Last Update Submit

September 17, 2024

Conditions

Keywords

ileostomyminimally invasive surgeryReduced-Port Fusion Surgerystoma complication

Outcome Measures

Primary Outcomes (1)

  • Overall complication rate of stoma

    Observe and assess for stoma complications

    7, 30, and 90 days after surgery

Secondary Outcomes (6)

  • DET(Discoloration,Erosion and Tissue overgrowth) score

    7, 30, and 90 days after surgery

  • Stomal skin infection rate

    7, 30, and 90 days after surgery

  • Parastostomy trocar incision infection rate

    7, 30, and 90 days after surgery

  • Parastomal hernia rate

    7, 30, and 90 days after surgery

  • Stoma Pain Score

    7, 30, and 90 days after surgery

  • +1 more secondary outcomes

Study Arms (2)

Reduced-Port Fusion Surgery Group

EXPERIMENTAL

Recive preoperative trocar/stoma fusion positioning and intraoperative trocar/stoma fusion surgery

Procedure: Reduced-Port Fusion Surgery

Traditional surgery group

ACTIVE COMPARATOR

Recive traditional preoperative stoma positioning and traditional stoma surgery

Procedure: Traditional surgery

Interventions

(1) The Joint Trocar/Stoma Zone will be delineated by the stoma therapist. (2) The placement of the fusion point will involve collaboration between the surgeon and stoma therapist. This will be based on the surgeon\'s trocar placement plan and the stoma therapist\'s positioning principles. (3) Follow the principles of modified stomal positioning. (4) The surgeon will insert the main trocar based on the preoperative positioning point. During stoma creation, the 12 mm main trocar incision will be extended to 25-30 mm to create an ileostomy.

Reduced-Port Fusion Surgery Group

(1) The stoma therapists perform stoma positioning using traditional stoma positioning method. The surgeon will determine the primary trocar location, ensuring it does not overlap with the stoma site. (2) The surgeon will insert the primary trocar based on the preoperative positioning point and conduct the surgery. During stoma creation, the surgeons create ileal stoma according to the preoperative stoma positioning point.

Traditional surgery group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • After preoperative evaluation, patients scheduled for laparoscopic/robotic colorectal surgery (rectum, sigmoid colon, left colon) who are planned to undergo prophylactic ileostomy.
  • No serious systemic infection or immunosuppression.
  • Over 18 years of age.
  • Eastern Cooperative Oncology Group Performance Status: 0-1
  • The expected survival time \> 6 months.
  • The subjects voluntarily participate and sign the informed consent

You may not qualify if:

  • Any skin infectious diseases in the abdominal wall.
  • Use hormones and immunosuppressive drugs within 1 month before surgery.
  • The time between operation and the last chemotherapy was less than 1 month.
  • Any previous ostomy surgery.
  • Any serious active infection or uncontrollable infection that requires systematic treatment.
  • A clear history of neurological or psychiatric disorders.
  • Subjects may not be able to complete the study for other reasons.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

Shanghai, China, 200092, China

RECRUITING

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

September 16, 2024

First Posted

September 19, 2024

Study Start

September 6, 2024

Primary Completion

December 31, 2025

Study Completion

December 31, 2025

Last Updated

September 19, 2024

Record last verified: 2024-09

Data Sharing

IPD Sharing
Will share

In this study personal information and data such as patient history, physical examination results, surgical records, and study questionnaire data will be collected. These data will be used to evaluate the efficacy and safety of the new procedure and for academic publication. The researcher will treat the patients\' personal data confidentially and anonymize the data and information in any public release of the results of the study.

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR

Locations